Key Takeaways
- On March 23, ARK Invest divested 39,362 shares of Bullish (BLSH) totaling approximately $1.56 million through its ARKK and ARKW funds
- Bullish shares advanced 4.16% during the same trading session, finishing near $39.55
- This followed an earlier divestment of 103,379 BLSH shares valued at roughly $3.93 million on March 20
- ARK previously accumulated around 2.1 million BLSH shares for approximately $58–$60 million during a nine-day February 2026 buying period
- Wall Street analysts maintain a Moderate Buy rating on BLSH with a consensus price target of $47.83, suggesting potential upside of approximately 20.9%
Cathie Wood’s investment firm ARK Invest offloaded a total of 39,362 shares in Bullish (BLSH) during Monday’s trading session on March 23, representing approximately $1.56 million in value, coinciding with a 4.16% advance in the stock price.
The divestment occurred across two exchange-traded funds: ARKK (ARK Innovation ETF) shed 31,154 shares, while ARKW (ARK Next Generation Internet ETF) disposed of 8,208 shares. Bullish concluded the session at approximately $39.55 per share.
This transaction represents part of a broader selling pattern. Three trading days prior, on March 20, ARK had already liquidated 103,379 BLSH shares worth approximately $3.93 million — a substantially larger transaction that received less attention than Monday’s activity.
Combined, the two-day selling activity totals 142,741 shares with an aggregate value of roughly $5.5 million. This reduction comes from a position that ARK accumulated through sustained purchasing over several months.
During February 2026, ARK executed an intensive nine-day acquisition campaign in BLSH, accumulating roughly 2.1 million shares at an estimated cost of $58–$60 million. These acquisitions occurred following a post-earnings decline in the stock.
Financial Performance Highlights
Bullish delivered fourth-quarter 2025 adjusted revenue of $92.5 million alongside adjusted EBITDA of $44.5 million, representing year-over-year growth in both metrics. The company recorded a net loss of $563.6 million, although adjusted net income showed improvement to $28.9 million.
Digital asset transaction volume reached $64.3 billion during the quarter, reflecting a modest decline. Management provided 2026 guidance for subscription, services, and other revenue in the range of $220 million to $250 million.
Full-year adjusted operating expenses are projected to fall between $210 million and $230 million.
Understanding ARK’s Strategic Moves
The current selling activity appears to reflect tactical portfolio management rather than a fundamental shift in investment thesis. ARK Invest has demonstrated a consistent pattern of acquiring BLSH shares during price weakness and reducing positions during strength — Monday’s transaction aligns perfectly with this approach, occurring as the stock rallied more than 4%.
ARK is simultaneously reallocating capital toward biotechnology opportunities. During the same session, the firm purchased 98,722 shares of 10X Genomics (TXG) valued at $1.89 million, with TXG also posting a 4.08% gain.
Cryptocurrency-related equities such as BLSH typically exhibit significant volatility correlated with Bitcoin price movements and regulatory developments, making them attractive candidates for profit-taking following periods of outperformance.
According to TipRanks, BLSH holds a Moderate Buy consensus rating derived from four Buy recommendations and two Hold ratings. The mean analyst price target stands at $47.83, representing potential upside of approximately 20.9% from current price levels.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
